1. Home
  2. HYFM vs CTXR Comparison

HYFM vs CTXR Comparison

Compare HYFM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYFM
  • CTXR
  • Stock Information
  • Founded
  • HYFM 1977
  • CTXR 2007
  • Country
  • HYFM United States
  • CTXR United States
  • Employees
  • HYFM N/A
  • CTXR N/A
  • Industry
  • HYFM Industrial Machinery/Components
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HYFM Industrials
  • CTXR Health Care
  • Exchange
  • HYFM Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • HYFM 17.3M
  • CTXR 18.7M
  • IPO Year
  • HYFM 2020
  • CTXR N/A
  • Fundamental
  • Price
  • HYFM $4.34
  • CTXR $1.29
  • Analyst Decision
  • HYFM Hold
  • CTXR Strong Buy
  • Analyst Count
  • HYFM 2
  • CTXR 3
  • Target Price
  • HYFM $7.00
  • CTXR $53.00
  • AVG Volume (30 Days)
  • HYFM 11.2K
  • CTXR 838.3K
  • Earning Date
  • HYFM 08-12-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • HYFM N/A
  • CTXR N/A
  • EPS Growth
  • HYFM N/A
  • CTXR N/A
  • EPS
  • HYFM N/A
  • CTXR N/A
  • Revenue
  • HYFM $176,650,000.00
  • CTXR N/A
  • Revenue This Year
  • HYFM $5.45
  • CTXR N/A
  • Revenue Next Year
  • HYFM $5.33
  • CTXR $365.90
  • P/E Ratio
  • HYFM N/A
  • CTXR N/A
  • Revenue Growth
  • HYFM N/A
  • CTXR N/A
  • 52 Week Low
  • HYFM $1.50
  • CTXR $0.65
  • 52 Week High
  • HYFM $8.55
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • HYFM 56.32
  • CTXR 42.28
  • Support Level
  • HYFM $3.88
  • CTXR $1.40
  • Resistance Level
  • HYFM $4.73
  • CTXR $1.72
  • Average True Range (ATR)
  • HYFM 0.34
  • CTXR 0.15
  • MACD
  • HYFM -0.01
  • CTXR -0.06
  • Stochastic Oscillator
  • HYFM 60.20
  • CTXR 5.45

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: